111 (YI) Receivables - Other (2018 - 2019)
111's (YI) quarterly Receivables - Other came in at $86831.0 in Q4 2019, up 282.4% year-on-year from $22706.8 in Q4 2018, and up 282.4% quarter-over-quarter from $22706.8 in Q4 2018.
111 (YI) Receivables - Other (2018 - 2019) Analysis & Trends
111 has disclosed Receivables - Other across 2 years of filings, most recently posting $86831.0 for Q4 2019.
- Receivables - Other for Q4 2019 came in at $86831.0, up 282.4% year-over-year; the trailing twelve-month figure through Dec 2019 was $86831.0 (up 282.4% YoY), and the FY2019 annual result was $88634.7, up 272.82% from the prior year.
- Receivables - Other came in at $86831.0 for Q4 2019 at 111, up from $22706.8 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $86831.0 in Q4 2019 to a low of $22706.8 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2018 | 22,706.85 |
| Dec 31, 2018 | 22,706.85 |